How Photobiomodulation Works
Every therapeutic claim begins at the level of the cell.
Understanding why photobiomodulation works means looking inside the cell itself. Here's the accepted mechanistic model — from light absorption in the mitochondria through to the effects that support tissue repair — explained in plain terms, including where the science is still evolving.
Mitochondria, ATP, and Cytochrome c Oxidase
Mitochondria produce ATP (adenosine triphosphate) — the molecule cells use as their primary energy currency — via a chain of enzymes in the mitochondrial membrane. The final enzyme in this chain, cytochrome c oxidase, is widely regarded as the principal light-absorbing molecule responsible for many of PBM's cellular effects.
When cytochrome c oxidase absorbs red or near-infrared light, its capacity to drive ATP production is thought to be enhanced under appropriate dosing, producing a modest, transient increase in cellular energy availability. In practical terms: the light acts as a gentle metabolic input that helps cells already engaged in repair — like muscle cells recovering from exercise — do that job more efficiently.
Nitric Oxide and Blood Flow
Nitric oxide can bind to and temporarily inhibit cytochrome c oxidase, particularly in metabolically stressed tissue. One hypothesis proposes that red and near-infrared light displaces this bound nitric oxide, relieving a brake on mitochondrial respiration and supporting local blood flow. This is one of several proposed mechanisms — not a single settled explanation, and we're clear about that distinction.
Reactive Oxygen Species and Cell Signalling
A brief, controlled increase in reactive oxygen species (ROS) — which at low, transient levels act as normal signalling molecules — is a well-documented downstream effect of PBM. This modest signal is understood to activate genes involved in cell survival, proliferation, and anti-inflammatory activity: the biochemical link between a few minutes of light exposure and the longer-lasting effects people notice afterward.
The Biphasic Dose Response
PBM follows what's called a biphasic, or “Arndt-Schulz,” dose-response curve: too little light produces no measurable effect, an appropriate dose produces benefit, and excessive doses can produce a neutral or even inhibitory effect. This is why dosing — wavelength, power density, total energy delivered — is a core determinant of outcome, and why VITARA prioritises doses that sit within ranges supported by the published literature.
Inflammation
PBM's relationship with inflammation is modulatory, not uniformly suppressive. At appropriate doses, PBM has been shown in laboratory and animal studies to reduce pro-inflammatory signalling and support the transition from acute inflammation into tissue repair.
Collagen and Skin
Fibroblasts — the cells that produce collagen and other structural skin components — respond to PBM at appropriate wavelengths and doses by increasing proliferation, migration, and collagen-related gene activity. This is the mechanistic basis for PBM's role in skin health and wound-healing research.
Our Perspective
We're deliberately careful in how we talk about mechanism. Where the literature describes a well-characterised pathway — like mitochondrial ATP production — we say so plainly. Where a mechanism is still one hypothesis among several — like the nitric-oxide pathway — we say that too, rather than letting a tidy explanation stand in for settled proof.